MFAP4 and fibrosis: To optimize stratification of patients according to MFAP4 serum level, we determined rule‐in and rule‐out cut‐offs for advanced fibrosis and cirrhosis by setting specificity (to rule‐in) or sensitivity (to rule‐out) to 90%.